Mucus Clearance Devices Market

Global Mucus Clearance Devices Market: Overview

Mucus clearance devices help cleared mucus-clogged airways for people with respiratory illnesses. These devices known to improve lifespan of people with critical illnesses such as COPD. Additionally, it promises to improve life quality significantly, in addition to exercise. The growth of the mucus clearance devices market is expected to be robust as it promises relief in several respiratory illnesses like Bronchitis, Atelectasis, Cystic Fibrosis, Asthma, COPD, among others.  

Global Mucus Clearance Devices Market: Notable Developments

Zephyr Receives FDA Approval

Zephyr, a breakthrough designated device by the FDA has been approved by the FDA patients suffering from severe emphysema. Emphysema is part of chronic respiratory COPD illnesses which are on the rise. It is a progressive lung disease, which is often caused by smoking. It is estimated that among all the patients suffering from emphysema, over 80 to 90 percent are regular smokers. World Health Organization estimates that COPD is expected to become the third leading cause of death worldwide. Hence, the FDA approval of Zephyr is expected to create several new opportunities in transport, distribution, and retail in the global mucus clearance devices market.

FDA Designated Breakthrough Device to Enter the Market Soon

The FDA has given a ‘breakthrough device’ designation to the RejuvenAir System. The device promises to rapidly freeze the epithelial layers of airways. In preliminary trials, it was found to be preserve the extracellular matrix while simultaneously destroying the mucus producing goblet cells. The extracellular matrix cell can help regenerate health cells. This is a major boost for the mucus clearance devices market as the Bronchitis disease did not have a cure earlier. It is estimated that there are over 8.6 million patients in the US suffering from this illness and it is most common form of COPD. The parent company is expected to carry out small trials in 30 locations across the US and Canada in the near future. Additionally, the result of the earlier study are already published in the American Journal of Respiratory and Critical Care Medicine in 2017. The breakthrough designation by the FDA, the curability of a major disease, and growing cases of COPD spell significant growth for the mucus clearance devices market in the near future.

Global Mucus Clearance Devices Market: Drivers and Restraints

The mucus clearance devices market is expected to register robust growth in the near future. It is estimated that there are 65 million people suffering from COPD or the Chronic Obstructive Pulmonary Disease. Additionally, 3 million of these die each year worldwide. Respiraroty illnesses like Asthama affect over 334 million people globally. It is also one of the major chronic illnesses effecting children in the near future. It affects 14% of all children globally. Chronic illnesses like lung cancer kill about 1.6 million people each year. The deadliest version of cancer is also on the rise, thanks to rising consumption of tobacco. World Health Organization estimates that toxic air affects 2 billion people worldwide. Among these, nearly 1 billion are affected by tobacco smoke, making them an easy target for a deadly disease.

Global Mucus Clearance Devices Market: Geographical Analysis

The global mucus clearance devices market is expected to register robust growth in North America and Asia Pacific. In both these regions, respective FDAs in China and US are encouraging strong trend of innovation in the pharmaceutical industry. This includes streamlining approval processes, encouraging norms for trials, among others. The encouragement has resulted in many new innovations and subsequent approvals. The rising innovation, the increasing funding for new devices, and rising chronic respiratory illnesses are expected to drive robust growth for the mucus clearance devices market in the near future.